on October 27, 2005
Published online before print October 27, 2005, doi: 10.1161/01.ATV.0000193624.28251.83
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 16, 2005
Accepted on October 19, 2005
What Does It Take to Make the Perfect Clot?
Dougald M. Monroe and Maureane Hoffman *
From the Pathology and Laboratory Medicine Service (M.H.), Durham Veterans Affairs Medical Center and Department of Pathology, Duke University Medical Center, Durham, and Carolina Cardiovascular Biology Center and Department of Medicine (D.M.M., M.H.), University of North Carolina, Chapel Hill, NC.
* To whom correspondence should be addressed. E-mail: maureane.hoffman{at}med.va.gov.
Abstract--The coagulation process has been conceptualized as being primarily dependent on adequate levels of the coagulation proteins. This concept was based on the clear relationship between the bleeding tendency and factor levels in hemophilia. The field is now evolving toward conceptualizing coagulation as being actively regulated by the specialized cellular components of the process. Rather than conceiving coagulation as only a "cascade" of proteolytic reactions, the coagulation reactions occur as overlapping steps on cell surfaces. Components of the old "extrinsic’" and "intrinsic" pathways of coagulation can be thought of as participating in the initiation and propagation of coagulation reactions, respectively. Thus, these pathways are not redundant as they are portrayed in the cascade model, but play distinct and complementary roles. Our understanding of how specific cellular features control the processes of hemostasis and thrombosis is developing rapidly. This review discusses some aspects of the cellular control of coagulation.
This article has been cited by other articles:
 |
|
 |
|
  B. Dahlback Advances in understanding pathogenic mechanisms of thrombophilic disorders Blood, July 1, 2008; 112(1): 19 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mittermayr, W. Streif, T. Haas, D. Fries, C. Velik-Salchner, A. Klingler, E. Oswald, C. Bach, M. Schnapka-Koepf, and P. Innerhofer Hemostatic Changes After Crystalloid or Colloid Fluid Administration During Major Orthopedic Surgery: The Role of Fibrinogen Administration Anesth. Analg., October 1, 2007; 105(4): 905 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ramot and A. Nyska Invited Review: Drug-Induced Thrombosis--Experimental, Clinical, and Mechanistic Considerations Toxicol Pathol, February 1, 2007; 35(2): 208 - 225. [Abstract] [PDF]
|
|
|
|
 |
|
 K. W. Mahaffey and R. C. Becker The Scientific Community's Quest to Identify Optimal Targets for Anticoagulant Pharmacotherapy Circulation, November 28, 2006; 114(22): 2313 - 2316. [Full Text] [PDF]
|
|
|
|
|
|
M. Hoffman, A. Harger, A. Lenkowski, U. Hedner, H. R. Roberts, and D. M. Monroe Cutaneous wound healing is impaired in hemophilia B Blood, November 1, 2006; 108(9): 3053 - 3060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Porschewski, M. A.-M. Grattinger, K. Klenzke, A. Erpenbach, M. R. Blind, and F. Schafer Using Aptamers as Capture Reagents in Bead-Based Assay Systems for Diagnostics and Hit Identification J Biomol Screen, October 1, 2006; 11(7): 773 - 781. [Abstract] [PDF]
|
|